Skip to content

The quickly placed Magnetic Anchor-Guided ESD Traction Microsystems Adjuvant ESD therapy

A Study on the Effectiveness and Safety of the quickly placed Magnetic Anchor-Guided ESD Traction Microsystems

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041543
Enrollment
Unknown
Registered
2020-12-28
Start date
2020-12-31
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastrointestinal cancer

Interventions

experimental group:Use the magnetic anchor traction microsystem
control group:Standard ESD

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Endoscopic or imaging examination revealed the presence or pathological biopsy of digestive tract tumors to determine the nature of the lesions: early cancer, precancerous lesions (adenomas, atypical hyperplasia, etc.), submucosal tumors (lipomas, stromal tumors, carcinoids, etc .); (2) According to white light endoscopy, combined with staining, amplification and endoscopic ultrasonography, the lesions were limited to the mucosal layer and the submucosal layer without lymphatic metastasis.

Exclusion criteria

Exclusion criteria: (1) presence of pacemaker or implantable cardioverter defibrillator; (2) other organs advanced malignancies; (3) severe heart and/or lung disease; (4) severe hematologic diseases; (5) severe coagulation dysfunction; (6) uncontrolled hypertension and/or diabetes mellitus; (7) pregnant or lactating women; (8) with lesions with depth of invasion exceeding SM2 and/or peripheral lymph node metastasis or even distant metastasis; (9) not considered appropriate by researchers.

Design outcomes

Primary

MeasureTime frame
Whether remove the lesion completely;Whether get Satisfactory mucosal visual field;Time of dissection;

Secondary

MeasureTime frame
Occurrence of complications;

Countries

China

Contacts

Public ContactXueyan Zhang

The Second Affiliated Hospital of Harbin Medical University

zxycxw@sina.com+86 15134556861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026